Case Report: Effective Treatment With Pyrotinib and Capecitabine in a Heavily Pretreated Locally Advanced Breast Cancer Harboring Both HER2 Overexpression and Mutant

The prognosis for female patients with locally advanced breast cancer (LABC) has improved with the emergence of novel drugs, especially for those who have HER2 overexpression or ERBB-2 amplification. Trastuzumab-based regimen has been the paradigm in guidelines as first-line therapy, whereas many pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhichao, Xu, Junnan, Wang, Yan, Wu, Jie, Sun, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553255/
https://www.ncbi.nlm.nih.gov/pubmed/34722261
http://dx.doi.org/10.3389/fonc.2021.715554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553255/
https://www.ncbi.nlm.nih.gov/pubmed/34722261
http://dx.doi.org/10.3389/fonc.2021.715554

Ejemplares similares